174 related articles for article (PubMed ID: 29637404)
1. Long-acting olanzapine injection during pregnancy and breastfeeding: a case report.
Manouilenko I; Öhman I; Georgieva J
Arch Womens Ment Health; 2018 Oct; 21(5):587-589. PubMed ID: 29637404
[TBL] [Abstract][Full Text] [Related]
2. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants.
Gardiner SJ; Kristensen JH; Begg EJ; Hackett LP; Wilson DA; Ilett KF; Kohan R; Rampono J
Am J Psychiatry; 2003 Aug; 160(8):1428-31. PubMed ID: 12900304
[TBL] [Abstract][Full Text] [Related]
3. Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.
Mitchell M; Kothare P; Bergstrom R; Zhao F; Jen KY; Walker D; Johnson J; McDonnell D
Clin Ther; 2013 Dec; 35(12):1890-908. PubMed ID: 24184052
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine pamoate for the treatment of schizophrenia.
Naber D
Expert Opin Pharmacother; 2011 Mar; 12(4):627-33. PubMed ID: 21254860
[TBL] [Abstract][Full Text] [Related]
5. Outcome of infants exposed to olanzapine during breastfeeding.
Gilad O; Merlob P; Stahl B; Klinger G
Breastfeed Med; 2011 Apr; 6(2):55-8. PubMed ID: 21034242
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine: a review of rapid and long-acting parenteral formulations.
Owen RT
Drugs Today (Barc); 2010 Mar; 46(3):173-81. PubMed ID: 20467591
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of olanzapine: Easy and reliable method for clinical correlation.
Junutula SP; Dubasi SK; Reddy Padide SG; Miryala GK; Koppolu MS; Bandaru Sheshagiri SB; Eggadi V
Indian J Pharmacol; 2021; 53(1):2-5. PubMed ID: 33975992
[TBL] [Abstract][Full Text] [Related]
8. Determination of olanzapine for therapeutic drug monitoring in schizophrenia patients by LC/MS method.
Albayrak M; Kadioglu Y; Yaman ME; Senol O; Oral E
Biomed Chromatogr; 2019 Apr; 33(4):e4468. PubMed ID: 30549068
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine excretion in human breast milk: estimation of infant exposure.
Croke S; Buist A; Hackett LP; Ilett KF; Norman TR; Burrows GD
Int J Neuropsychopharmacol; 2002 Sep; 5(3):243-7. PubMed ID: 12366877
[TBL] [Abstract][Full Text] [Related]
10. Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism.
McDonnell DP; Detke HC; Bergstrom RF; Kothare P; Johnson J; Stickelmeyer M; Sanchez-Felix MV; Sorsaburu S; Mitchell MI
BMC Psychiatry; 2010 Jun; 10():45. PubMed ID: 20537130
[TBL] [Abstract][Full Text] [Related]
11. D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia.
Mamo D; Kapur S; Keshavan M; Laruelle M; Taylor CC; Kothare PA; Barsoum P; McDonnell D
Neuropsychopharmacology; 2008 Jan; 33(2):298-304. PubMed ID: 17443131
[TBL] [Abstract][Full Text] [Related]
12. Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia.
Park EJ; Amatya S; Kim MS; Park JH; Seol E; Lee H; Shin YH; Na DH
Arch Pharm Res; 2013 Jun; 36(6):651-9. PubMed ID: 23543652
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine pamoate: a stick in time? A review of the efficacy and safety profile of a new depot formulation of a second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Jan; 63(1):140-50. PubMed ID: 18834452
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine long-acting injection: a review of its use in the treatment of schizophrenia.
Frampton JE
Drugs; 2010 Dec; 70(17):2289-313. PubMed ID: 21080745
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months.
Whitworth A; Stuppaeck C; Yazdi K; Kralovec K; Geretsegger C; Zernig G; Aichhorn W
J Psychopharmacol; 2010 Jan; 24(1):121-3. PubMed ID: 18801835
[TBL] [Abstract][Full Text] [Related]
16. Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature.
Teodorescu A; Ifteni P; Moga MA; Burtea V; Bigiu N
BMC Psychiatry; 2017 Aug; 17(1):311. PubMed ID: 28851326
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine and quetiapine use during breastfeeding: excretion into breast milk and safe breastfeeding strategy.
Aydin B; Nayir T; Sahin S; Yildiz A
J Clin Psychopharmacol; 2015 Apr; 35(2):206-8. PubMed ID: 25679127
[No Abstract] [Full Text] [Related]
18. Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness?
Stiegler A; Schaletzky R; Walter G; Wüst R; Abele H; Goelz R; Farger G; Wiatr G; Fallgatter AJ; Batra A
Psychopharmacology (Berl); 2014 Aug; 231(15):3067-9. PubMed ID: 24938920
[No Abstract] [Full Text] [Related]
19. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.
Altamura AC; Sassella F; Santini A; Montresor C; Fumagalli S; Mundo E
Drugs; 2003; 63(5):493-512. PubMed ID: 12600227
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine treatment during breast feeding: a case report.
Lutz UC; Wiatr G; Orlikowsky T; Gaertner HJ; Bartels M
Ther Drug Monit; 2008 Jun; 30(3):399-401. PubMed ID: 18520614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
